Projekt · Dnr 2020-03099 · Källa: Vinnova
Oxynitridbiokeramer för säker och långsiktig virusinaktivering
- Koordinator
- Uppsala universitet, Institutionen för materialvetenskap
- Projekttid
- 2020-10-01 till 2021-06-30 (avslutat)
- Beviljat bidrag
- 940 986 SEK
- Diarienummer
- 2020-03099
Beskrivning
The aiming nitride powders were oxidised, characterised and their antiviral properties were tested against copper, an established antiviral agent. The results indicated that oxidised nitride ceramics were highly effective in binding and inactivating SARS-CoV-2, adenovirus, H1N1, and Norovirus after from one minute to hours of contact. The in-situ testing in the animal hospital has not shown a clear difference before the targeting materials and the control, but bacteria. One reason could be no enough virus in the places where we placed. The aiming nitride powders were oxidised, characterised and their antiviral properties were tested against copper, an established antiviral agent. The results indicated that oxidised nitride ceramics were highly effective in binding and inactivating SARS-CoV-2, adenovirus, H1N1, and Norovirus after from one minute to hours of contact. The in-situ testing in the animal hospital has not shown a clear difference before the targeting materials and the control, but bacteria. One reason could be no enough virus in the places where we placed.
Hittar Vinnova inte sidan? Sök på diarienumret hos Vinnova.
Liknande
-
Centrum för III-Nitrid teknologi (C3NiT)
Linköpings universitet · 2017-07-01 · 29 600 000 SEK · Projekt
C3NiT has focused on stimulating and boosting the Swedish Industry-Academia Cluster on group III-nitrides and elevating its position to be among the leading wide bandgap clusters and be a preferred partner in major EU initiatives. C3NiT has developed the research infrastructures for material growth …
-
E!11481, E-OxidoCurin, HDXperts AB
HDxperts AB · 2017-10-01 · 4 888 259 SEK · Projekt
All the goals of the project were fulfilled. 1) A new water-soluble lead compound LCTA2940 was synthesized. 2) The TrxR1 target was validated, and the mechanism of interaction and ROS dependent action was elucidated. 3) Using proteomics, we identified additional targets. 4) In vivo LCTA2940 effectiv…
-
Klinisk utvärdering av ett nytt Ultra-snabbt Antibiotikakänslighetstest för Blodinfektioner.
Astrego Diagnostics AB · 2018-12-01 · 1 671 000 SEK · Projekt
1) Production of Astrego’s disposable cartridges to be used for the aimed verification and implementation of design improvements: this objective has been fulfilled. 2) Verification of the Astrego® Technology for direct AST from blood culture bottles in a prospective clinical study: This objective wa…
-
Studie av reaktion och porositetsbildning mellan keramisk kärna och Haynes 282
TPC Components AB · 2021-11-15 · 325 000 SEK · Projekt
This project aims to investigate the core-metal reaction and porosity in cast Haynes 282 component using alternative core materials or core coatings. Because the results of this project were mostly inconclusive it is suggested that further investigation is required. It is inconclusive if microporosi…
-
E!11019, OptiFemVac, Abera Bioscience AB
Abera Bioscience AB · 2017-04-01 · 2 351 980 SEK · Projekt
The purpose was to engineer bacterial outer membrane vesicles (OMVs) into a versatile and modular platform for recombinant vaccine development. Technology was developped to couple high amounts of antigenic proteins to OMV particles and vaccine candidates against either Zika virus or Humano papiloma …